Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson’s disease; both advancing toward IND-enabling studies Advancing ABC-enabled Tau, Alpha Synuclein and NLRP3 siRNA programs targeting peripheral delivery of novel therapies for neurodegenerative disorders Independent interim analysis for the PROGRESS-AD Phase 2 clinical trial of nivisnebart (AL101) in ...

DENVER, Nov. 06, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenue from continuing operations of $147.5 million, an increase of 5.3% compared to $140.1 million for the quarter ended September 30, 2024. Pro Forma Revenue increased 5.3% to $148.3 million, compared to $140.8 million for the quarter ended Septe ...

Recent Federal Wildfire Initiatives and Financing Transaction to Accelerate GrowthBELGRADE, Mont., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for the third quarter ended September 30, 2025. Third Quarter and Recent Highlights: Record third quarter revenue of $67.9 million brings nine-month revenue to $114.3 millionThi ...

CHINO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced financial results for its 2025 third quarter ended September 30, 2025. Third Quarter 2025 Highlights Record quarterly net sales of $124.5 million, up 10.4 percent, from $112.8 million in the prior-year quarter.Gross profit decreased to $42.9 million, from $43.5 m ...

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q3 2025 results include a non-recurring benefit from the Employee Retention Tax Credit. Non-GAAP adjusted figures exclude this benefit. A reconciliation of GAAP to non-GAAP results is included. Q3 2025: Sales $61.0mm, +11% (+12% organic)Gross margin 75.3% (+750 ...

Encouraging Phase 1 data on ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-⍺ (FR⍺), presented at the AACR-NCI-EORTC ConferenceFirst patient dosed in Phase 1 clinical trial of ZW251 for the treatment of hepatocellular carcinomaAchievement of $25.0 million development milestone from Johnson & Johnson Innovative MedicineEarned royalties of $1.0 million based on Ziihera® net product sales by Jazz and BeOne Medicines for 3Q-2025Completed share repurchases of $22.7 million under share repurchas ...

Consistent Product Revenue, Customer Momentum and Strong Liquidity Positioning the Company for New AI Technology Integration and Corporate Initiatives AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware”, or the “Company”) (NASDAQ: PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today reported financial results for the third quarter ended September 30, 2025. Financial High ...

- Grew Revenue 6%, Compared to Third Quarter 2024 - - Board Authorizes an Additional $12 Million for Share Repurchases - SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the third quarter ended September 30, 2025. The following figures represent continuing operations unless otherwise stated. Third Quarter 2025 Financial Highlights Grew ...

核心观点 - 公司公布2025年第三季度业绩，营收符合指引区间，调整后EBITDA亏损略优于指引 [1] - 公司正在进行业务转型，包括国际分销模式过渡和有计划的门店关闭，这影响了短期财务表现 [4][10][16] - 管理层强调将专注于支持产品引擎、控制成本、增强流动性以重振增长 [3] 第三季度财务表现 - 第三季度净营收3300万美元，同比下降23.3%，主要归因于结构性调整 [4][9] - 毛利率为43.2%，同比下降120个基点，受销售渠道组合变化及美国业务关税增加影响 [5][9] - 销售、一般和行政费用为2170万美元，占营收65.7%，同比下降，主要因各项运营费用降低 [6] - 营销费用为1170万美元，占营收35.5%，同比增加，主要用于支持新品推出的数字广告 [7] - 净亏损2030万美元，净亏损率61.6% [7][9] - 调整后EBITDA亏损改善至1570万美元，略优于公司指引 [8][9] 九个月累计财务表现 - 2025年前九个月净营收1.048亿美元，同比下降21.7% [10] - 前九个月毛利率为42.7%，低于去年同期的47.5%，原因包括渠道组合变化、促销活动增加及库存调整 [11] - 前九个月净亏损5770万美元，净亏损率55.1% [13] - 前九个月调整后EBITDA亏损4690万美元 [14] 资产负债表与现金流 - 截至2025年9月30日，公司持有现金及等价物2370万美元，在5000万美元资产支持循环信贷额度下未偿还借款1230万美元 [9][15] - 库存为4310万美元，同比下降25.0%，符合预期 [9][15] - 前九个月经营活动所用净现金为5180万美元 [35] 2025年财务指引更新 - 将2025年全年营收指引下调至1.61亿-1.66亿美元，此前为1.65亿-1.80亿美元，调整反映了国际分销模式过渡和美国门店关闭的影响 [16][19] - 维持全年调整后EBITDA亏损指引中点，范围为亏损6300万-5700万美元 [19] - 预计第四季度营收5600万-6100万美元，调整后EBITDA亏损1600万-1000万美元 [18][19] 业务运营与战略重点 - 公司门店总数从2023年9月30日的60家减少至2025年9月30日的23家，反映了大规模的门店关闭计划 [41][42][43] - 国际市场的运营模式正从直接销售向分销商模式过渡 [41][43] - 管理层计划在假日季重点突出礼品创意和品牌核心原则（舒适、风格、可持续性），以捕捉消费者心智份额 [3]

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended September 30, 2025. This represents results for the second quarter of the fiscal year ending March 31, 2026. The Board of Directors of the Company has declared a quarterly cash dividend of $0.28 per share of Class A common stock, payable on December 15, 2025, ...